EMBARK

By Brennan / Belser Founded 2022 Subcategory psychedelic-assisted
Key text EMBARK Psychedelic Therapy for Depression (Brennan & Belser, 2024, Oxford University Press)
Psychedelic Focus: Integration + Processing Variable (structured phases: preparation, medicine sessions, integration) Individual (dyadic facilitation team)

Core Mechanism

Six domains the model holds to be common in psychedelic states organize preparation and integration; four 'care cornerstones' are meant to keep delivery ethical, trauma-informed, and culturally responsive. The structure organizes the therapy rather than explaining how psychedelics work.

Ontology

A whole person whose psychedelic experience activates multiple dimensions simultaneously (existential, somatic, relational, affective-cognitive) requiring a multi-domain therapeutic response rather than a single-mechanism model

Therapeutic Voice

"You keep coming back to what your body was doing when it started. Let's stay there a while before we go to what it meant."

View of the Person

A person who is not reducible to the mechanism a given drug acts on: one session touches meaning, body, relationship, and mood at once


Evidence

Not in major clinical guidelines; recognized in psychedelic-assisted therapy research context

EMBARK is the psychotherapy support model used alongside Cybin's CYB003 (a synthetic psilocybin analog, not psilocybin itself) in that company's Phase 1/2a MDD trial; Cybin reported 79% remission via press release (not yet peer-reviewed) for the combined drug-plus-support protocol: published data do not isolate EMBARK's own contribution

Emerging; Frontiers in Psychology model description (2022)

Developed at Cybin, a clinical-stage psychedelics company, in response to gaps its authors identified in existing psychedelic-assisted therapy models: too little attention to the body, to ethics, and to cultural difference. Released open-access rather than licensed, and built to be transdiagnostic and trans-drug, so the same scaffold is used for psilocybin, MDMA, ketamine, or DMT. Cybin reports more than 4,000 clinicians registered for the free foundational course at embarkapproach.com.


Conditions

Epistemology

EmpiricistPhenomenologicalContemplative

Blind Spots

Developed within a pharmaceutical research context (Cybin); limited independent replication; open-source status means variable implementation quality; requires specialized training not yet standardized across programs

Contraindications

Same medical and psychiatric contraindications as the specific psychedelic being used; active psychosis, severe cardiovascular conditions, medications with dangerous interactions


Training

EMBARK foundational training (open access online); EMBARK Certified Facilitator program for clinical trial contexts

EMBARK Certified Facilitator

Open-access foundational course: ~4 hrs; full certification: intensive training with supervision

Open-access course: free; certification training: varies by program

Find a Trained Therapist

Fluence ↗ Fluence
Psychedelic Support ↗ Psychedelic Support
Third Wave ↗ Third Wave
Psychable ↗ Psychable

Equity & Cultural Adaptations

Cross-cultural adaptationsLGBTQ+ affirming adaptationsAccessibility accommodations

Philosophical Roots

Grof (non-ordinary states); James (varieties of religious experience); harm reduction philosophy; CBT, ACT, and psychodynamic traditions integrated

Related Modalities

Test Yourself

What does EMBARK stand for?

Show answer

Existential-Spiritual, Mindfulness, Body Aware, Affective-Cognitive, Relational, Keeping Momentum: six domains that commonly emerge in psychedelic experiences.


Sources